Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bionomy Health vs TeleCareSpot

Bionomy Health
Graded #182

Lower grade

vs+1.1000000000000085
TeleCareSpot
Graded #160

Higher grade

The verdict

TeleCareSpot takes it — 67.7/100 to 66.6/100, but only just.

TeleCareSpot grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month… Bionomy Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBionomy Health +4
47
43
Dose & formulationTeleCareSpot +8
75
83
Clinical oversightTeleCareSpot +5
78
83
Labs & monitoringBionomy Health +10
62
52
FulfillmentTeleCareSpot +3
89
92
Contract termsTeleCareSpot +8
53
61
Bionomy Health · left barTeleCareSpot · right bar

The numbers

MetricBionomy HealthTeleCareSpot
WeighScore66.6/10067.7/100
GradeCC
Scorecard rank#182#160
Semaglutide$189/mo (starting dose, compounded)$299/mo (all doses, plus a separate fee, compounded)
Tirzepatide$249/mo (compounded)$399/mo
Coverage48 states48 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Bionomy Health

Graded #182 · C

Strengths

  • Cancellation is genuinely unconditional: no subscription, no card on file, no auto-renewal, no cancellation fee — you pay per refill
  • Prices are published before intake on a dedicated GLP-1 page, and the same figures appear in the site's own llms.txt
  • Available in 48 states

Where it loses points

  • The $189 is a starting rate, not a flat one: the page says 'From', the product card says 'Starter', and doses are titrated every four weeks with no published price for the dose you end up on
  • The homepage says muscle preservation is 'included' while the GLP-1 page sells a Muscle Preserve Pack at $109/mo as a separate line item
  • No FDA-approved pathway and no oral route — the site does not mention Wegovy, Ozempic, Zepbound or Mounjaro at all
  • Not available in Alaska or Hawaii
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
TeleCareSpot

Graded #160 · C

Strengths

  • Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
  • Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
  • Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
  • DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
  • Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Not available in Alaska, Mississippi, or New Jersey
  • The compounding pharmacy partner is not named
  • A separate weight-loss consultation fee applies (credited toward your medication package if approved)
  • Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard